Lv5
830 积分 2024-02-17 加入
Cd73: An Emerging Checkpoint for Cancer Immunotherapy
2天前
已关闭
Neoantigen-Based Immunotherapy in Lung Cancer: Advances, Challenges and Prospects
2天前
已完结
Immunotherapy with CAR-Modified T Cells: Toxicities and Overcoming Strategies
2天前
已完结
Chimeric Antigen Receptor T Cell Based Immunotherapy for Cancer
2天前
已完结
The Discovery of Biomarkers in Cancer Immunotherapy
2天前
已完结
Cd73: An Emerging Checkpoint for Cancer Immunotherapy
2天前
已关闭
Efficacy of cascade-primed cell infusion as an adjuvant immunotherapy with concurrent chemotherapy for patients with non–small-cell lung cancer: A retrospective observational study with a 5-year follow-up
2天前
已完结
IL‐33/ST2 as a potential target for tumor immunotherapy
2天前
已完结
Targeting neoantigens for cancer immunotherapy
2天前
已完结
Identification of Key Pathways and Genes Related to Immunotherapy Resistance of LUAD Based on WGCNA Analysis
2天前
已完结
皖公网安备34019202002308
